The presence of PD-L1 on LECs induces T cell tolerance through PD1/PD-L1 interaction and lack of co-stimulation (98), thus restricting CD8+ T cell activation and reducing their accumulation in the tumor microenvironment (95). The gene discussed is CD8A; the disease is neoplasm.